Navigation Links
FDA Clears First Medical Product Made From Yulex(R) Natural Rubber
Date:4/24/2008

FDA provides 510(k) on examination gloves made from U.S.-sourced guayule

rubber that is naturally safe for people with Type I latex allergy

MARICOPA, Ariz., April 24 /PRNewswire/ -- Yulex Corporation, a company that produces natural rubber found to be safe for medical devices, received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market the first medical device made from guayule, a desert crop native to the U.S. Southwest. The examination gloves made with patented Yulex(R) natural rubber, and cleared by the FDA, do not contain proteins associated with allergic reactions to latex products from Hevea brasiliensis, and are naturally Hevea latex-free.

(Photo: http://www.newscom.com/cgi-bin/prnh/20080424/LATH031)

"We have worked closely with Hevea latex-sensitive individuals, the medical device industry, ASTM International (ASTM) and the FDA to bring this safe alternative to the marketplace," says Jeffrey Martin, president and chief executive officer of Yulex Corporation. "We are pleased with the FDA's guidance and look forward to launching several other guayule-based products currently in the pipeline."

"With more hospitals becoming latex-safe and latex-free, Yulex natural rubber now provides a safe alternative to both healthcare workers and patients who are sensitized to Hevea latex," says Dr. Katrina Cornish, senior vice president of research and development at Yulex. While a scientist at the United States Department of Agriculture -- Agricultural Research Service (USDA-ARS) in the 1990s, Dr. Cornish developed and patented the first process for producing guayule natural rubber for medical devices.

After the AIDS crisis increased latex glove use dramatically in the 1980s, several Type I latex allergy deaths were reported due to the high amounts of residual Hevea protein contained in medical products. As a consequence, the FDA initiated strict regulatory requirements of all products made with Hevea natural rubber latex, and the USDA-ARS began conducting research and development to identify a safer, domestic source for latex. Yulex Corporation then licensed basic technology from the USDA-ARS, and, after years of development, Yulex established guayule as an industrial crop and developed the manufacturing technologies to produce guayule natural rubber commercially.

In 2006, ASTM created a new latex category specifying, for the first time, safety standards based on protein content without lowering the performance standards to accommodate synthetic materials, and Yulex natural rubber is the only material that meets the category's safety and performance requirements.

To learn more about Yulex Corporation, visit http://www.yulex.com.

ABOUT YULEX CORPORATION

A renewable and sustainable enterprise, Yulex Corporation applies intelligent crop science and proprietary clean technology to create biobased medical products from guayule (why-YOU-lee), a plant native to the North American high desert and now an international industrial crop. Yulex(R) natural rubber provides medical device manufacturers with a natural rubber that is naturally free of the allergens associated with Type I Latex Allergy. Through Yulex Corporation's innovations, a new industry producing natural rubber, green fuel and non-toxic adhesives is born. For more, visit http://www.yulex.com.


'/>"/>
SOURCE Yulex Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. DJO Incorporateds Pending Merger With ReAble Therapeutics Clears U.S. Antitrust Review
2. Federal Trade Commission Clears Kyphons Acquisition of Non-Vertebroplasty Spine-Related Assets of Disc-O-Tech
3. FDA Clears OmniWave(TM) Endovascular System for Clot Removal in Peripheral Blood Vessels
4. FDA Clears Biospace meds Revolutionary Low Dose Xray Imager
5. New filter clears up fiber optic communications
6. FDA Clears Expanded Use of Xofts Axxent(R) Electronic Brachytherapy System for all Radiation Therapy Indications
7. Device That Clears Debris From Artery Aids Blood Flow in PCI
8. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
9. GlaxoSmithKline Recognizes University of Michigans Dr. Daniel F. Hayes as the First Recipient of the Gianni Bonadonna Breast Cancer Award
10. Kewaunee Scientific Announces First Quarter Results and Quarterly Dividend
11. Genmab Announces 2007 First Half Year Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... -- WuXi AppTec, a leading global pharmaceutical, biotechnology ... today announced that it has acquired HD Biosciences ... contract research organization (CRO). After completion of acquisition, ... WuXi, and will continue to focus on growing ... acquisition will further strengthen WuXi,s R&D capability from ...
(Date:1/19/2017)... GAITHERSBURG, Md. , Jan. 19, ... Altimmune, Inc., a privately-held immunotherapeutics company targeting infectious ... agreement for the merger of PharmAthene and Altimmune ... Novartis Venture Fund, HealthCap, Truffle Capital and Redmont ... and diversified immunotherapeutics company with four clinical stage ...
(Date:1/19/2017)... , ... January 18, 2017 , ... ... tech innovators, engineers, and scientists from around the world, was today awarded the ... awards program is based entirely on merit and decided upon by a dedicated ...
(Date:1/19/2017)...  Northwest Biotherapeutics, Inc. (OTCQB: NWBO) ("NW Bio"), a ... operable and inoperable solid tumor cancers, announced today that ... NW Bio, will present at the Phacilitate Immunotherapy World ... Regency Hotel in Miami, Florida . ... "New Therapeutic Approaches – Expanding the Reach of Cancer ...
Breaking Biology Technology:
(Date:1/6/2017)... , Jan. 6, 2017  Privately-held CalciMedica, ... studies in healthy volunteers of a novel calcium ... treat acute pancreatitis. Acute pancreatitis, ... a mild disorder, but can be very serious.  In ... and sepsis, where extended hospital stays, time in ...
(Date:1/4/2017)...  CES 2017 – Valencell , the leading ... the launch of two new versions of its ... sensor modules that incorporate the best of Valencell,s ... The two new designs include Benchmark BE2.0, a ... Benchmark BW2.0, a 2-LED version of its original ...
(Date:12/20/2016)... 20, 2016 The rising popularity of ... leasing is stoking significant interest in keyless access ... Bluetooth low energy (BLE), biometrics and near-field communication ... wave of wireless technologies in the automotive industry. ... advanced access systems opens the market to specialist ...
Breaking Biology News(10 mins):